DUBLIN, Jan. 17, 2022 /PRNewswire/ -- The "Global Genetic Testing Market Forecasts for Applications and Technologies 2021-2025 - COVID-19 Pandemic Impact Updates with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.
This report forecasts the market size out to 2025. The report includes detailed breakouts for 14 countries and 5 regions.
Is genomic cancer testing bouncing back? What has happened to Direct to Consumer testing? Will all newborns receive Whole Genomic Sequencing at birth?
The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry.
Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
Genetic Testing Recent Developments
Progenity Revenues Fall on COVID-19 Effect
Natera Launches Tumor Genomic Profiling Assay
23andMe To Go Public
Guardant Health to Offer Tumor Tissue Sequencing
Ancestry Quits Health Offering
DTC Firm MyDNA Merges With Gene by Gene
Aetna Coverage for NIPT to Include All Pregnancies
Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing
Tumor, Germline Testing of Cancer Patients Can Give Discordant Results
Invitae Completes Acquisition of ArcherDx
Prenetics Receives $15M Investment
Sanford Health Invests $800K in TruGenomix as Part of PTSD Test Alliance
Preconception Carrier Screening Trial Begins in Australia
Genetic Testing Clinical Use Just Beginning
Fulgent Genetics Q1 Revenues Jump 44 Percent
Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders
Natera Terminates Qiagen Agreement for Developing NGS-Based Genetic Tests
Invitae Acquires Three Companies: YouScript, Genelex, Diploid
PerkinElmer SCID Test Chosen for Newborn Screening Evaluation in England
Germline Cancer Risk Mutations Sometimes Reported in Tumor Testing
Blueprint Genetics, Archimedlife to Launch Genetic Testing in North America
Invitae to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients
Phosphorus Offers DNA Testing to Assess Disease Risk
Arivale Shuts Down Personalized Wellness Business
ArcherDX Acquires Baby Genes
MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay
Thermo Fisher Purchases 9 Percent Stake in Yourgene Health
Invitae Partners to Expand Free Epilepsy Genetic Testing Program
Illumina, Chinese Firm Partner on NGS System for Genetic Disease Dx
NanoString Technologies Prices $103.5M Common Stock Offering
Canine Consumer Genomics Firm Embark Veterinary Raises $10M
Yourgene Health to Acquire Elucigene
Helix, AdventHealth Partner on Genetic Screening Study
Factors Driving Growth
Genetic Discoveries Creating New Diagnostic Markets
Aging Population a Boon for Diagnostics
Pharmacogenomics Drives Further Growth.
Oncology and Liquid Biopsy Enter New Era
Fertility Practice Growth drives market
Direct to Consumer begins to break out
Factors Limiting Growth
Increased Competition Lowers Price
Testing usage analysis curtailing growth
Wellness has a downside
Instrumentation and Automation
Instruments Key to Market Share
Bioinformatics Plays a Role
Diagnostic Technology Development
Next Generation Sequencing Fuels a Revolution.
Impact of NGS on pricing
POCT/Self Testing Disruptive Force
Pharmacogenomics Blurs Diagnosis and Treatment
CGES Testing, A Brave New World
Biochips/Giant magneto resistance based assay
Market Participants Play Different Roles
Independent lab specialized/esoteric
Independent lab national/regional
Independent lab analytical
Public National/regional lab
Independent Genetic Testing Lab
Genetic Tests -Types, Examples and Discussion
Preimplantation Genetic Diagnosis- An Emerging Market
Prenatal Diagnosis - New Technologies Create Opportunity
Predictive and Presymptomatic Testing
Hospital's Testing Share
Economies of Scale
Hospital vs. Central Lab
Physician Office Lab's
Physician's and POCT
Profiles of Key Companies
10. Genomics, Inc
Admera Health, LLC
Agena Bioscience, Inc
Baylor Miraca Genetics Laboratories
Beckman Coulter, Inc.
Becton, Dickinson and Company
BGI Genomics Co. Ltd
Bio-Rad Laboratories, Inc.
Caris Molecular Diagnostics
Complete Genomics, Inc. - A BGI Company
Datar Cancer Genetics Limited
FUJIFILM Wako Diagnostics
GE Global Research
GE Healthcare Life Sciences
Gene by Gene, Ltd.
Genetron Health (Beijing) Co., Ltd.
Genomics Personalized Health (GPH)
HTG Molecular Diagnostics
Human Longevity, Inc.
MDNA Life SCIENCES, Inc
Novogene Bioinformatics Technology Co., Ltd.
Oxford Nanopore Technologies
Personal Genome Diagnostics
Roche Molecular Diagnostics
Singlera Genomics Inc
Sure Genomics, Inc.
Tempus Labs, Inc
Thermo Fisher Scientific Inc
For more information about this report visit https://www.researchandmarkets.com/r/x178q7
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets